| 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European … Authors/Task Force Members, SV Konstantinides, A Torbicki, G Agnelli, ... European heart journal 35 (43), 3033-3080, 2014 | 4265 | 2014 |
| Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation CTP Morten L Hansen 1, Rikke Sørensen, Mette T Clausen, Marie Louise Fog ... Arch Intern Med, 2010 | 3702* | 2010 |
| Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million … TK Schramm, GH Gislason, L Køber, S Rasmussen, JN Rasmussen, ... Circulation 117 (15), 1945-1954, 2008 | 687 | 2008 |
| The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: a nationwide cohort study JB Olesen, C Torp-Pedersen, ML Hansen, GYH Lip Thrombosis and haemostasis 107 (06), 1172-1179, 2012 | 657 | 2012 |
| Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort study JB Olesen, GYH Lip, J Lindhardsen, DA Lane, O Ahlehoff, ML Hansen, ... Thrombosis and haemostasis 106 (10), 739-749, 2011 | 616 | 2011 |
| Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction … TK Schramm, GH Gislason, A Vaag, JN Rasmussen, F Folke, ML Hansen, ... European heart journal 32 (15), 1900-1908, 2011 | 602 | 2011 |
| Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ... Archives of internal medicine 169 (2), 141-149, 2009 | 381 | 2009 |
| The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study C Selmer, JB Olesen, ML Hansen, J Lindhardsen, AMS Olsen, ... Bmj 345, 2012 | 361 | 2012 |
| Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study C Selmer, JB Olesen, ML Hansen, LM von Kappelgaard, JC Madsen, ... The Journal of Clinical Endocrinology & Metabolism 99 (7), 2372-2382, 2014 | 346 | 2014 |
| Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study AN Bonde, GYH Lip, AL Kamper, PR Hansen, M Lamberts, K Hommel, ... Journal of the American College of Cardiology 64 (23), 2471-2482, 2014 | 339 | 2014 |
| Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study M Lamberts, GH Gislason, GYH Lip, JF Lassen, JB Olesen, AP Mikkelsen, ... Circulation 129 (15), 1577-1585, 2014 | 316 | 2014 |
| Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations F Folke, FK Lippert, SL Nielsen, GH Gislason, ML Hansen, TK Schramm, ... Circulation 120 (6), 510-517, 2009 | 267 | 2009 |
| Bleeding risk in ‘real world’patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort JB Olesen, GYH Lip, PR Hansen, J Lindhardsen, O Ahlehoff, ... Journal of Thrombosis and Haemostasis 9 (8), 1460-1467, 2011 | 253 | 2011 |
| Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ... Circulation 116 (7), 737-744, 2007 | 240 | 2007 |
| Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study R Sørensen, G Gislason, C Torp-Pedersen, JB Olesen, EL Fosbøl, ... BMJ open 3 (5), e002758, 2013 | 228 | 2013 |
| Risk of myocardial infarction and death associated with the use of nonsteroidal anti‐inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study EL Fosbøl, GH Gislason, S Jacobsen, F Folke, ML Hansen, TK Schramm, ... Clinical Pharmacology & Therapeutics 85 (2), 190-197, 2009 | 222 | 2009 |
| Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011–2013 JB Olesen, R Sørensen, ML Hansen, M Lamberts, P Weeke, ... EP Europace 17 (2), 187-193, 2014 | 209 | 2014 |
| Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction AMS Olsen, GH Gislason, P McGettigan, E Fosbøl, R Sørensen, ... Jama 313 (8), 805-814, 2015 | 202 | 2015 |
| Differences between out-of-hospital cardiac arrest in residential and public locations and implications for public-access defibrillation F Folke, GH Gislason, FK Lippert, SL Nielsen, P Weeke, ML Hansen, ... Circulation 122 (6), 623-630, 2010 | 189 | 2010 |
| Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy ML Hansen, RMHG Jepsen, JB Olesen, MH Ruwald, D Karasoy, ... EP Europace 17 (1), 18-23, 2015 | 176 | 2015 |
Gunnar GislasonProfessor of Cardiology, Copenhagen University Hospital Herlev and Gentofte在 regionh.dk 的电子邮件经过验证
